4.4 Article

COVID-19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice Network

Related references

Note: Only part of the references are listed.
Article Rheumatology

Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

Parikshit Sen et al.

Summary: In this study, hesitancy in patients with autoimmune rheumatic diseases (AIRDs) towards COVID-19 vaccines was investigated. The results showed a decrease in hesitancy, but an increase in concerns over the long-term safety of the vaccine. Patients with idiopathic inflammatory myopathies (IIMs) expressed more skepticism towards vaccine science and had more concerns over long-term safety.

RHEUMATOLOGY (2023)

Article Rheumatology

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5

Jeffrey R. Curtis et al.

Summary: This study aims to provide guidance to rheumatology healthcare providers on the use of COVID-19 vaccines in patients with RMDs. Through a review of literature and expert opinions, consensus statements were developed to provide direction on the use of COVID-19 vaccines in RMD patients, despite limited direct evidence.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis

Jin Kyun Park et al.

Summary: This study found that discontinuing methotrexate for 1 week after seasonal influenza vaccination is noninferior to discontinuing for 2 weeks in terms of inducing a satisfactory vaccine response in patients with rheumatoid arthritis.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Public, Environmental & Occupational Health

From COVID-19 Vaccine Hesitancy to Vaccine Acceptance: Results of a Longitudinal Survey

Kimberly A. Fisher et al.

Summary: A study found that about half of initially vaccine-hesitant individuals chose to receive the COVID-19 vaccine. Factors influencing the vaccination decision for those initially hesitant included educational attainment, knowledge of COVID-19, and a doctor's recommendation. For those initially planning not to be vaccinated, factors such as gender, political affiliation, COVID-19 concerns, and knowledge influenced their likelihood of receiving the vaccine. The main reasons for vaccination were to protect oneself and others.

PUBLIC HEALTH REPORTS (2023)

Article Rheumatology

Perceived Risk of SARS-CoV-2 at the Start of the COVID-19 Pandemic and Subsequent Vaccination Attitudes in Patients With Rheumatic Diseases A Longitudinal Analysis

Roland Duculan et al.

Summary: This longitudinal study examined the association between perspectives on SARS-CoV-2 risk at the start of the pandemic and clinical course and vaccination intent at follow-up. The results showed that perceived infection risk at enrollment was not associated with clinical status and vaccination intent at follow-up.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)

Article Rheumatology

Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study

Jeffrey R. Curtis et al.

Summary: Compared with the general population, patients with rheumatoid arthritis (RA) are at a higher risk of COVID-19, including increased risk of hospitalization and in-hospital death. Systemic therapies do not further increase the risk, except for non-TNFi biologics.

JOURNAL OF RHEUMATOLOGY (2022)

Article Medicine, General & Internal

Changes in COVID-19 Vaccine Hesitancy Among Black and White Individuals in the US

Tasleem J. Padamsee et al.

Summary: This study compares changes in vaccine hesitancy between Black and White individuals in the US and explores mechanisms that may explain the differences. The findings suggest that Black individuals initially had comparable vaccination intentions to White individuals but experienced larger increases over time, potentially due to changes in beliefs about the vaccine.

JAMA NETWORK OPEN (2022)

Article Rheumatology

Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey

Lisa G. Rider et al.

Summary: The study found that disease flares requiring changes in treatment after COVID-19 vaccination were uncommon among patients with systemic rheumatic diseases. Certain SRD types like systemic lupus erythematosus, psoriatic arthritis, and polymyalgia rheumatica were associated with higher odds of flare, while idiopathic inflammatory myopathies were associated with lower odds. The Oxford-AstraZeneca vaccine, a prior reaction to a non-COVID-19 vaccine, and female sex were identified as potential risk factors for disease flares following vaccination.

RHEUMATOLOGY (2022)

Article Medicine, General & Internal

Questionnaire Survey on Vaccination Willingness and the Status of COVID-19 Vaccination Among Patients with Rheumatic Disease: A Single-Center Survey in China

Feng Wang

Summary: The study found that males were more likely to underestimate the risk of COVID-19 infection compared to females, and medical workers had a higher perception of COVID-19 infection risk than nonmedical workers. 35.73% of the patients were hesitant to be vaccinated, while 64.27% were willing to accept vaccination. Patient sex and occupation were key factors influencing vaccination willingness.

PATIENT PREFERENCE AND ADHERENCE (2022)

Article Immunology

The COVID-19 vaccine: Attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases

Jiali Chen et al.

Summary: The study found that autoimmune inflammatory rheumatic diseases (AIIRD) patients had negative attitudes towards the COVID-19 vaccine, mainly due to concerns about potential exacerbation of the disease and additional adverse reactions. Patients' sociodemographic characteristics and concerns about COVID-19 disease and vaccines had a significant impact on vaccination willingness.

RHEUMATOLOGY & AUTOIMMUNITY (2022)

Article Rheumatology

Influenza Vaccine Hesitancy and Its Determinants Among Rheumatology Patients

Valeria Valerio et al.

Summary: This study investigated the hesitancy and associated factors related to influenza vaccine uptake among Canadian patients with rheumatic disease. The study found that more than 40% of patients were likely to refuse or uncertain about receiving the vaccine, contributing to suboptimal vaccine coverage in this population. Interventions are needed to address these concerns, particularly in the COVID-19 era.

ACR OPEN RHEUMATOLOGY (2022)

Article Rheumatology

Acceptability of Vaccines Against Preventable Infections Including Coronavirus Disease 2019 Among Patients With Rheumatic Disease

Sara K. Tedeschi et al.

Summary: Vaccine acceptability, including toward COVID-19 vaccines, was high among patients with systemic rheumatic disease at an academic medical center cohort. Physician recommendation is a key factor for vaccine uptake.

ACR OPEN RHEUMATOLOGY (2022)

Article Biotechnology & Applied Microbiology

Knowledge and attitudes about influenza vaccination in rheumatic diseases patients

Gabriel Figueroa-Parra et al.

Summary: This study investigated the knowledge and attitudes about influenza vaccination among patients with rheumatic diseases and found that concerns about safety, efficacy, side effects, fear of the vaccine, and knowledge of cost can diminish vaccine uptake. These factors are related to confidence, complacency, and convenience as components of vaccine hesitancy in this population.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Medicine, General & Internal

Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy

Lila J. Finney Rutten et al.

Summary: The success of COVID-19 vaccination programs relies on scientific safety data, high acceptance rates, and population coverage. However, vaccine hesitancy and complacency about vaccination may undermine the success of these programs. Multilevel, evidence-based strategies are needed to address behavior change and vaccine hesitancy.

MAYO CLINIC PROCEEDINGS (2021)

Review Immunology

International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples

Eric Robinson et al.

Summary: The global willingness to uptake COVID-19 vaccines is decreasing while refusal to vaccinate is increasing. Factors such as gender, age, lower income and education levels, and belonging to ethnic minority groups are associated with lower intentions to vaccinate.

VACCINE (2021)

Editorial Material Medicine, General & Internal

Covid-19 vaccine hesitancy among ethnic minority groups

Mohammad S. Razai et al.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Rheumatology

COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey

Priyanka Gaur et al.

Summary: In patients with AIRD, older individuals are more willing to get vaccinated than younger ones, while those with lower education levels are more hesitant. Common reasons for hesitancy include indecision, fear of vaccine side effects, and disease worsening.

RHEUMATOLOGY INTERNATIONAL (2021)

Editorial Material Medicine, General & Internal

Covid-19 vaccination hesitancy

Mohammad S. Razai et al.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Rheumatology

Interventions to improve vaccine acceptance among rheumatoid arthritis patients: a systematic review

Vincent Gosselin Boucher et al.

CLINICAL RHEUMATOLOGY (2019)

Article Biotechnology & Applied Microbiology

Impact of a physician recommendation

Paul M. Darden et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)